U.S. SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                           Commission File No. 0-18849

(Check  One):  [  ]  Form  10-K  or  Form 10-KSB   [ ] Form 11-K   [ ] Form 20-F
[  X  ]  Form  10-Q  or  Form  10-QSB   [  ]  Form  N-SAR

For  Period  Ended:  June  30,  2001.

[  ]  Transition  Report  on  Form  10-K  or  Form  10-KSB
[  ]  Transition  Report  on  Form  20-F
[  ]  Transition  Report  on  Form  11-K
[  ]  Transition  Report  on  Form  10-Q  or  Form  10-QSB
[  ]  Transition  Report  on  Form  N-SAR

For  the  Transition  Period  Ended:  Not  Applicable

     Read  attached  instruction  sheet  before preparing form.  Please print or
type.

     Nothing  in  this  form shall be construed to imply that the Commission has
verified  any  information  contained  herein.

     If  the  notification  relates  to  a  portion of the filing checked above,
identify  the  Item(s)  to  which  the  notification  relates:  Not  Applicable

                                     Part I
                             Registrant Information

Full  Name  of  Registrant:  The  Female  Health  Company

Former  Name  if  Applicable:  Not  Applicable

Address  of  Principal  Executive  Office  (Street and Number):  875 N. Michigan
Avenue,  Suite  3660

City,  State  and  Zip  Code:  Chicago,  IL  60611


                                     Part II
                             Rules 12b-25(b) and (c)

     If  the  subject  report  could not be filed without unreasonable effort or
expense  and  the  registrant  seeks  relief  pursuant  to  Rule  12b-25(b), the
following  should  be  completed.  (Check  box  if  appropriate)

   |  (a)    The  reason described in reasonable detail in Part III of this form
   |         could not be eliminated  without  unreasonable  effort  or expense;
   |
   |  (b)    The  subject annual report, semiannual report, transition report on
   |         Form  10-K,  Form  10-KSB,  Form  20-F, Form 11-K or Form N-SAR, or
   |         portion  thereof  will be filed on or before the fifteenth calendar
[x]|         day  following  the  prescribed  due date; or the subject quarterly
   |         report or transition report on Form 10-Q or Form 10-QSB, or portion
   |         thereof will be filed on or before the fifth calendar day following
   |         the  prescribed  due  date;  and
   |
   |  (c)    The  accountant's  statement  or  other  exhibit  required  by
   |         Rule  12b-25(c)  has  been  attached  if  applicable.


                                    Part III
                                    Narrative

     State  below  in reasonable detail the reasons why Form 10-K, 10-KSB, 11-K,
20-F,  10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be
filed  within  the  prescribed  time period.  (Attached extra sheets if needed.)

     The  registrant  could  not  file  its annual report on Form 10-QSB for the
quarter  ended  June  30,  2001  on the prescribed filing date for the following
reasons:

                 The Company was not able to complete the Company's Form
            10-QSB  by  August  14,  2001,  the  required  filing  date,
            without  unreasonable  effort  and  expense  because  of the
            extraordinary demands upon management's time with respect to
            financing  and  other  activities in the weeks preceding the
            required  filing  date  for  the  Form  10-QSB.



                                        2
                                     Part IV
                                Other Information

     (1)     Name  and  telephone  number of person to contact in regard to this
notification:

O.B.  Parrish,  Chairman  and  Chief  Executive  Officer     312-280-1119

     (2)     Have  all other periodic reports required under section 13 or 15(d)
of  the  Securities Exchange Act of 1934 or section 30 of the Investment Company
Act  of  1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify  report(s).

                                                             [x]  Yes   [  ]  No

     (3)     Is  it  anticipated  that  any  significant  change  in  results of
operations  from  the  corresponding  period  for  the  last fiscal year will be
reflected  by  the  earnings  statements to be included in the subject report or
portion  thereof?

                                                             [x]  Yes   [  ]  No

                 The  Company  anticipates that its financial statements
            will  reflect  revenues  of  $2,296,590  and  net  income
            attributable  to  common  stockholders  of  $11,756  for the
            quarter  ended  June  30,  2001,  as compared to revenues of
            $1,377,932  and  a  net  loss  attributable  to  common
            stockholders  of  $865,702  for  the  quarter ended June 30,
            2000.

     The  Female Health Company has caused this notification to be signed on its
behalf  by  the  undersigned  thereunto  duly  authorized.

     Dated  this  15th  day  of  August,  2001.

                                              THE  FEMALE  HEALTH  COMPNAY

                                              BY      /s/  O.B.  Parrish
                                                ------------------------------
                                                O.B. Parrish, Chairman and
                                                Chief Executive Officer

                                        3